Therapeutic Inertia or Individualization? Delay in clinical management of type 2 diabetes mellitus.

Therapeutic Inertia or Individualization? Delay in clinical management of type 2 diabetes mellitus. Curr Med Res Opin. 2016 May 16;:1-8 Authors: Tanaka N, Kurose T, Seino Y Abstract Guidelines for treatment of patients with type 2 diabetes mellitus recommend that treatment should be intensified when the blood glucose level does not reach the treatment goal. However, in clinical situations, delays of initiation or intensification of treatment by healthcare providers often occur. Clinical inertia is defined as failure of a healthcare provider to initiate or intensify therapy when treatment goals are not achieved. Clinical inertia has been postulated to affect patient unfavorable outcome. While adjustment of medical therapy considering patient preferences, comorbidities, and unusual factors in treatment strategy for type 2 diabetes, i.e., individuation, is highly recommended, special efforts to avoid clinical inertia are required in real world, clinical settings to insure more appropriate medical care. Investigations are required to demonstrate any longitudinal differences in outcomes and benefits in more rigorously individualized diabetes therapeutic strategies. PMID: 27181181 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research